Jefferies on Cabaletta Bio Inc. (CABA): liking setup as co 'is heading into an inflection point'

March 23, 2026 4:57 PM

Jefferies analyst Roger Song reiterated a Buy rating and $14.00 price target on Cabaletta Bio Inc. (NASDAQ: CABA)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found